Veterinary Medicines

Cevac Transmune

Authorised
  • Infectious bursal disease virus, strain Winterfield 2512, Inactivated
Download as PDF

Product identification

Medicine name:
Cevac Transmune
CEVAC TRANSMUNE liofilizzato con diluente per sospensione iniettabile per polli
Active substance:
  • Infectious bursal disease virus, strain Winterfield 2512, Inactivated
Target species:
  • Chicken (embryonated eggs)
  • Chicken
Route of administration:
  • In ovo
  • Subcutaneous use

Product details

Active substance and strength:
  • Infectious bursal disease virus, strain Winterfield 2512, Inactivated
    0.10
    50% Protective Dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for suspension for injection
Withdrawal period by route of administration:
  • In ovo
    • Chicken (embryonated eggs)
  • Subcutaneous use
    • Chicken
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD09
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:
  • Cardboard box with 20 glass vials (Type I) of 13.5 ml containing 8000 doses, closed with a bromobutyl stopper and sealed with aluminium caps with plastic tear-off centres.
  • Cardboard box with 20 glass vials (Type I) of 10 ml containing 5000 doses, closed with a bromobutyl stopper and sealed with aluminium caps with plastic tear-off centres.
  • Cardboard box with 20 glass vials (Type I) of 10 ml containing 4000 doses, closed with a bromobutyl stopper and sealed with aluminium caps with plastic tear-off centres.
  • Cardboard box with 20 glass vials (Type I) of 10 ml containing 2500 doses, closed with a bromobutyl stopper and sealed with aluminium caps with plastic tear-off centres.
  • Cardboard box with 20 glass vials (Type I) of 10 ml containing 2000 doses, closed with a bromobutyl stopper and sealed with aluminium caps with plastic tear-off centres.
  • Cardboard box with single glass vial (Type I) of 13.5 ml containing 8000 doses, closed with a bromobutyl stopper and sealed with aluminium caps with plastic tear-off centres.
  • Cardboard box with single glass vial (Type I) of 10 ml containing 5000 doses, closed with a bromobutyl stopper and sealed with aluminium caps with plastic tear-off centres.
  • Cardboard box with single glass vial (Type I) of 10 ml containing 4000 doses, closed with a bromobutyl stopper and sealed with aluminium caps with plastic tear-off centres.
  • Cardboard box with single glass vial (Type I) of 10 ml containing 2500 doses, closed with a bromobutyl stopper and sealed with aluminium caps with plastic tear-off centres.
  • Cardboard box with single glass vial (Type I) of 10 ml containing 2000 doses, closed with a bromobutyl stopper and sealed with aluminium caps with plastic tear-off centres.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva Salute Animale S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva-Phylaxia Zrt.
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 103966
Date of authorisation status change:
Reference member state:
  • Hungary
Procedure number:
  • HU/V/0141/002
Concerned member states:
  • Bulgaria
  • Cyprus
  • Czechia
  • Estonia
  • France
  • Germany
  • Greece
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 19/09/2023
Updated on: 21/09/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."